Patten Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,319
| Closed | -$234K | – | 241 |
|
|
2022
Q2 | $234K | Buy |
4,319
+240
| +6% | +$13K | 0.08% | 217 |
|
|
2022
Q1 | $222K | Buy |
+4,079
| New | +$222K | 0.06% | 244 |
|
|
2019
Q1 | – | Sell |
-664
| Closed | -$32K | – | 333 |
|
|
2018
Q4 | $32K | Hold |
664
| – | – | 0.02% | 332 |
|
|
2018
Q3 | $33K | Hold |
664
| – | – | 0.01% | 373 |
|
|
2018
Q2 | $33K | Hold |
664
| – | – | 0.01% | 364 |
|
|
2018
Q1 | $32K | Hold |
664
| – | – | 0.01% | 362 |
|
|
2017
Q4 | $29K | Hold |
664
| – | – | 0.01% | 391 |
|
|
2017
Q3 | $34K | Hold |
664
| – | – | 0.01% | 367 |
|
|
2017
Q2 | $34K | Hold |
664
| – | – | 0.01% | 369 |
|
|
2017
Q1 | $34K | Hold |
664
| – | – | 0.01% | 347 |
|
|
2016
Q4 | $32K | Sell |
664
-2,012
| -75% | -$97K | 0.01% | 346 |
|
|
2016
Q3 | $142K | Buy |
2,676
+908
| +51% | +$48.1K | 0.07% | 203 |
|
|
2016
Q2 | $95.8K | Buy |
1,768
+304
| +21% | +$16.5K | 0.04% | 240 |
|
|
2016
Q1 | $74.2K | Hold |
1,464
| – | – | 0.04% | 259 |
|
|
2015
Q4 | $73.8K | Buy |
1,464
+1,000
| +216% | +$50.4K | 0.04% | 263 |
|
|
2015
Q3 | $22.3K | Hold |
464
| – | – | 0.01% | 357 |
|
|
2015
Q2 | $24.2K | Buy |
+464
| New | +$24.2K | 0.01% | 358 |
|